Anika Therapeutics, Inc. (ANIK): Company Cash Volume

Official company branding of Anika Therapeutics, Inc. (ANIK)

The cash position of Anika Therapeutics (ANIK) demonstrates liquidity dynamics, where the 0.04 mark reflects the latest data. The competition for clinics in the joint segment is conducted through long-term agreements, despite the risks associated with bioregenerative technologies. The business relies on proprietary hydrogel protocols to lock in surgeons. A steady stream of procedures ensures predictable cash flow, confirming the company's operational resilience.

Company Cash Funds: Anika Therapeutics, Inc. (ANIK) for 07/04/2022 - 11/21/2026

Summary analytical data breakdowns for anikatherapeutics.com (ANIK)

- stock exchange capitalization data:
Initial company analysis:Anika Therapeutics Inc. ANIK
Brand item of Anika Therapeutics

The scale of operations at Anika Therapeutics (ANIK) requires significant expenditures for sterile manufacturing and FDA certification. An analysis of liquidity levels allows for an assessment of the company's ability to fund capital expenditures without resorting to expensive loans. By examining cash reserve dynamics, an investor can determine whether management is effectively investing funds into the development of patent-protected products. A stable cash position confirms the asset's financial resilience amidst stringent industry regulation.

Analysis of competing companies

Company Cash Volume BSX|Company Cash Funds EW (Edwards Lifesciences Corporation)|Company Cash Funds ResMed RMD|Company Cash Volume Insulet Corp PODD|ZBH: Company Cash on Hand|Company Cash Balance COO (CooperVision)|ALGN (Align Technology, Inc.) - Company Cash on Hand|Globus Medical, Inc. - Company Cash Balance|TMDX (TransMedics Group Inc) - Company Cash Volume|Company Cash Reserve Alphatec Holdings ATEC|Company Cash Funds CryoLife (AORT)|Enovis Corporation (ENOV) - Company Cash Position|Integra LifeSciences Inc. - Company Cash on Hand|Company Cash Volume Establishment Labs ESTA|Beta Bionics, Inc. - Company Cash Volume|Company Liquid Assets IRADIMED Corp IRMD|Embecta (EMBC) - Company Cash Funds|Company Total Cash Volume TNDM (Tandem Corp)|Company Cash Funds axogeninc.com|Company Cash on Hand SI-BONE, Inc. (SIBN)|Company Cash Volume OFIX|Bioventus Corp - Company Cash and Cash Equivalents|Company Cash Funds orthopediatrics.com KIDS|TMCI: Company Cash and Cash Equivalents|SRTA: Company Cash on Hand|Carlsmed Inc - Company Total Cash Amount|RxSight (RXST) - Company Cash Funds|Company Cash on Hand ClearPoint|Company Cash on Hand STXS|Company Cash Reserve Neuronetics, Inc. STIM|Company Cash Volume SGHT|Company Cash on Hand Orchestra BioMed OBIO|Company Cash Funds InspireMD, Inc. NSPR|Company Cash Balance ZJYL|VANI - Company Cash Funds|Xtant Medical Holdings, Inc. - Company Total Cash Amount|NeuroOne (NMTC) - Company Cash Funds|Modular Med (MODD) - Company Cash Volume|Company Cash Funds Myomo, Inc|Company Cash on Hand Envoy Medical (COCH)|Company Cash Volume VVOS|NVNO (enVVeno Corp) - Company Cash Balance|Company Cash Volume SINT (Sintx Technologies)|TNON: Company Cash and Cash Equivalents|Lifeward - Company Cash Volume|Company Cash Balance AMIX (Autonomix Medical)|IVF: Company Cash Volume|Company Cash Position Bone Biologics Corporation BBLG|Company Cash on Hand AXNX|BIOLASE, Inc. (BIOL) - Company Liquid Assets|Company Cash Volume DYNT|Company Liquid Assets Paragon 28|Company Cash Volume INVO (INVO Bioscience, Inc.)